Advertisement

Topics

BioFocus renews C.I.R. (French Research Tax Credit) accreditation

11:20 EDT 10 Aug 2010 | BioPortfolio

Saffron Walden, UK; 8 June May 2010 – BioFocus, a leading provider of gene-to-clinical candidate drug discovery services, today announced that it had been notified by the French Ministry of Higher Education and Research, that its CIR accreditation had been renewed.

The accreditation allows eligible French companies to benefit from significant tax relief (Crédit d'Impôt sur la Recherche) on research carried out by BioFocus on their behalf until 2013. The accreditation is an extension of the current agreement, in place since 2008, covering work at both UK and The Netherlands research facilities.

“The renewal of our CIR accreditation allows our eligible clients the opportunity to receive 30% of their R&D costs in tax credits” said Richard Gordon, Senior Director, Sales and Marketing. “Clients who have benefited from this facility over the last three years can continue to do so and access BioFocus’ evolving discovery platform”.

For further information concerning the Crédit d'Impôt sur la Recherche please click here.

About BioFocus

BioFocus aims to expand its partners’ drug pipelines by accelerating the gene-to-clinical candidate discovery process. This is achieved through a comprehensive discovery platform, which includes target discovery in human primary cells, focused as well as diverse compound libraries, in vitro and cell-based screening, structural biology, medicinal chemistry, ADME/PK services, supported by unique chemogenomic and informatics tools, and compound library acquisition, storage and distribution services. As a service division of Galapagos, BioFocus has over 250 employees in three countries worldwide.

BioFocus® is a trademarks of Galapagos NV and/or its affiliates © Copyright 2010 Galapagos NV.
 

Product enquiries BioFocus:

Richard Gordon
Tel: +44 1799 533 500 Email: richard.gordon@glpg.com


Media enquiries Alto Marketing Limited:
David Robinson
Tel: +44 1489 557 672 Email: davidr@alto-marketing.com
 

Product enquiries BioFocus: Richard Gordon Tel: +44 1799 533 500 Email: richard.gordon@glpg.com Media enquiries Alto Marketing Limited: David Robinson Tel: +44 1489 557 672 Email: davidr@alto-marketing.com NEXT ARTICLE

More From BioPortfolio on "BioFocus renews C.I.R. (French Research Tax Credit) accreditation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...